4-Methyl-N-pentylidenebenzenesulfonamide

Catalog No.: 
ACOZPH297
CAS No.: 
320750-67-2
Molecular Formula: 
C12H17NO2S
Molecular Weight: 
239.34
4-Methyl-N-pentylidenebenzenesulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$75.00In stockInquiry
250mg97%$127.00In stockInquiry
1g97%$348.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Methyl-N-pentylidenebenzenesulfonamide
IUPAC Name(E)-4-methyl-N-pentylidenebenzenesulfonamide
Molecular FormulaC12H17NO2S
Molecular Weight239.34
SMILESO=S(C1=CC=C(C)C=C1)(/N=C/CCCC)=O
InChI KeyNVGWIATZZGIJIS-JLHYYAGUSA-N
SynonymBenzenesulfonamide, 4-methyl-N-pentylidene-;4-Methyl-N-pentylidenebenzenesulfonamide
CAS No.320750-67-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACOZPH297 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZPH297 route product structure diagram
    ACOZPH297320750-67-2In Stock
Inquiry

2. ACOZPH297 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZPH297 route product structure diagram
    ACOZPH297320750-67-2In Stock
Inquiry

3. ACOZPH297 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOZPH297 route product structure diagram
    ACOZPH297320750-67-2In Stock
Inquiry

Comments (0)